Search

Nessan A Bermingham

from Boston, MA
Age ~51
Get Report
Also known as:
Nessan Anthony Bermingham, Nessan A Birmingham, Nessan Berminham, Anthony Bermingham Nessan
Phone and address:
13 Cazenove St, Boston, MA 02116
(617) 236-4645
Connected to:
Alan J Bermingham, 45Arthur B Bermingham, 51Brianna D Bermingham, 30Chad W Bermingham, 56Haley M Bermingham, 37Jason K Bermingham, 48Jon E Bermingham, 61June A Bermingham, 58Kensey C Bermingham, 37Kristi R Bermingham, 47

Nessan Bermingham Phones & Addresses

  • 13 Cazenove St, Boston, MA 02116 (617) 236-4645
  • Brookline, MA
  • Quincy, MA
  • Miami Beach, FL
  • Jackson, WY
  • Nantucket, MA
  • New York, NY
  • Houston, TX

Work

Company: Atlas venture Dec 2012 Address: Cambridge MA Position: Venture partner/monsanto seed fund alliance

Education

Degree: PhD School / High School: Imperial College London 1993 to 1999 Specialities: Molecular Biology

Industries

Biotechnology

Resumes

Resumes

Nessan Bermingham Photo 1

Nessan Bermingham

View page
Location:
Boston, MA
Industry:
Biotechnology
Work:
Atlas Venture - Cambridge MA since Dec 2012
Venture Partner/Monsanto Seed Fund Alliance
Bio Equity Capital - Boston MA since Feb 2009
Managing Partner
California Institute of Regenerative Medicine since Jun 2011
Advisor
Room To Dream Foundation - Boston MA since Apr 2012
Board Member
Tal Medical - Boston MA since Feb 2011
Founding CEO & Advisor
Education:
Imperial College London 1993 - 1999
PhD, Molecular Biology

Publications

Us Patents

Rna-Editing Oligonucleotides And Uses Thereof

View page
US Patent:
20230104978, Apr 6, 2023
Filed:
Aug 5, 2022
Appl. No.:
17/817874
Inventors:
- Cambridge MA, US
Steven Robinette - Fremont NH, US
Nessan Bermingham - Boston MA, US
Mallikarjuna Reddy Putta - Lexington MA, US
Assignee:
Korro Bio, Inc. - Cambridge MA
International Classification:
C12N 15/11
Abstract:
The present disclosure features useful compositions and methods to treat disorders for which deamination of an adenosine in an mRNA produces a therapeutic result,

Rna-Editing Oligonucleotides And Uses Thereof

View page
US Patent:
20200399303, Dec 24, 2020
Filed:
Jan 22, 2020
Appl. No.:
16/749500
Inventors:
- Cambridge MA, US
Steven ROBINETTE - Fremont NH, US
Nessan BERMINGHAM - Boston MA, US
Mallikarjuna Reddy PUTTA - Lexington MA, US
International Classification:
C07H 19/16
C07H 19/06
Abstract:
The present disclosure features useful compositions and methods to treat disorders for which deamination of an adenosine in an mRNA produces a therapeutic result, e.g., in a subject in need thereof.

Rna-Editing Oligonucleotides And Uses Thereof

View page
US Patent:
20200392486, Dec 17, 2020
Filed:
Jan 22, 2020
Appl. No.:
16/749601
Inventors:
- Cambridge MA, US
Steven ROBINETTE - Fremont NH, US
Nessan BERMINGHAM - Boston MA, US
Mallikarjuna Reddy PUTTA - Lexington MA, US
International Classification:
C12N 15/11
Abstract:
The present disclosure features useful compositions and methods to treat disorders for which deamination of an adenosine in an mRNA produces a therapeutic result, e.g., in a subject in need thereof.

Rna-Editing Oligonucleotides And Uses Thereof

View page
US Patent:
20200385713, Dec 10, 2020
Filed:
Jan 22, 2020
Appl. No.:
16/749608
Inventors:
- Cambridge MA, US
Steven ROBINETTE - Fremont NH, US
Nessan BERMINGHAM - Boston MA, US
Mallikarjuna Reddy PUTTA - Lexington MA, US
International Classification:
C12N 15/11
A61K 31/7125
Abstract:
The present disclosure features useful compositions and methods to treat disorders for which deamination of an adenosine in an mRNA produces a therapeutic result, e.g., in a subject in need thereof.
Control profile
Nessan A Bermingham from Boston, MA, age ~51 Get Report